UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 107

Sortiert nach

Identification of a novel estrogen response element in the Breast Cancer Resistance Protein (ABCG2) gene

Cancer research (Chicago, Ill.), 2004-02, Vol.64 (4), p.1247-1251

2004

Volltextzugriff (PDF)

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer

Cancer research (Chicago, Ill.), 2006-03, Vol.66 (5), p.2815-2825

2006

Volltextzugriff (PDF)

Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post- transcriptional increases in cyclin D proteins

Cancer research (Chicago, Ill.), 2006-08, Vol.66 (15), p.7783-7792

2006

Volltextzugriff (PDF)

Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein

Cancer research (Chicago, Ill.), 2000, Vol.60 (1), p.47-50

2000

Volltextzugriff (PDF)

Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias

Cancer research (Chicago, Ill.), 2010-01, Vol.70 (2), p.447-452

2010

Volltextzugriff (PDF)

Targeting RNA Polymerase I with an Oral Small Molecule CX-5461 Inhibits Ribosomal RNA Synthesis and Solid Tumor Growth

Cancer research (Chicago, Ill.), 2011-02, Vol.71 (4), p.1418-1430

2011

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor and Mutant p53 Expand an Esophageal Cellular Subpopulation Capable of Epithelial-to-Mesenchymal Transition through ZEB Transcription Factors

Cancer research (Chicago, Ill.), 2010-05, Vol.70 (10), p.4174-4184

2010

Volltextzugriff (PDF)

The Kynurenine Pathway in Brain Tumor Pathogenesis

Cancer research (Chicago, Ill.), 2012-11, Vol.72 (22), p.5649-5657

2012

Volltextzugriff (PDF)

γ-Secretase Inhibitors Enhance Temozolomide Treatment of Human Gliomas by Inhibiting Neurosphere Repopulation and Xenograft Recurrence

Cancer research (Chicago, Ill.), 2010-09, Vol.70 (17), p.6870-6879

2010

Volltextzugriff (PDF)

Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)h:quinone oxidoreductase 1 Role of 17-AAG hydroquinone in heat shock protein 90 inhibition

Cancer research (Chicago, Ill.), 2005-11, Vol.65 (21), p.10006-10015

2005

Volltextzugriff (PDF)

Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib

Cancer research (Chicago, Ill.), 2006-08, Vol.66 (16), p.8163-8171

2006

Volltextzugriff (PDF)

Transport of methotrexate, methotrexate polyglutamates, and 17β-estradiol 17-(β-D-glucuronide) by ABCG2: Effects of acquired mutations at R482 on methotrexate transport

Cancer research (Chicago, Ill.), 2003-07, Vol.63 (14), p.4048-4054

2003

Volltextzugriff (PDF)

Differing Src Signaling Levels Have Distinct Outcomes in Drosophila

Cancer research (Chicago, Ill.), 2007-11, Vol.67 (21), p.10278-10285

2007

Volltextzugriff (PDF)

Characterization of Gene―Environment Interactions for Colorectal Cancer Susceptibility Loci

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8), p.2036-2044

2012

Volltextzugriff (PDF)

The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux

Cancer research (Chicago, Ill.), 2001-01, Vol.61 (2), p.739-748

2001

Volltextzugriff (PDF)

Letrozole inhibits Tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status

Cancer research (Chicago, Ill.), 2003-10, Vol.63 (19), p.6523-6531

2003

Volltextzugriff (PDF)

β-Glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells

Cancer research (Chicago, Ill.), 2003-12, Vol.63 (24), p.9023-9031

2003

Volltextzugriff (PDF)

Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues : Implications for drug resistance, tissue-specific expression, and alternative promoter usage

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (10), p.5007-5011

2006

Volltextzugriff (PDF)

LPA Receptor Heterodimerizes with CD97 to Amplify LPA-Initiated RHO-Dependent Signaling and Invasion in Prostate Cancer Cells

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (23), p.7301-7311

2011

Volltextzugriff (PDF)

Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux

Cancer research (Chicago, Ill.), 2000-07, Vol.60 (13), p.3514-3521

2000

Volltextzugriff (PDF)

The protein kinase Cβ-selective inhibitor, enzastaurin (LY317615.HCI), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts

Cancer research (Chicago, Ill.), 2005-08, Vol.65 (16), p.7462-7469

2005

Volltextzugriff (PDF)

Autoantibody Signatures Involving Glycolysis and Splicesome Proteins Precede a Diagnosis of Breast Cancer among Postmenopausal Women

Cancer research (Chicago, Ill.), 2013-03, Vol.73 (5), p.1502-1513

2013

Volltextzugriff (PDF)

Hedgehog Signaling Inhibition Blocks Growth of Resistant Tumors through Effects on Tumor Microenvironment

Cancer research (Chicago, Ill.), 2012-02, Vol.72 (4), p.897-907

2012

Volltextzugriff (PDF)

Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas

Cancer research (Chicago, Ill.), 2005-05, Vol.65 (9), p.3796-3805

2005

Volltextzugriff (PDF)

Serum antibodies to huntingtin interacting protein. 1: A new blood test for prostate cancer

Cancer research (Chicago, Ill.), 2005-05, Vol.65 (10), p.4126-4133

2005

Volltextzugriff (PDF)

1 – 25 von 107

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

Nur zeigenGeprüft (Peer-Review)

ThemaAntineoplastic Agents

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(107)

Publikationsform

Artikel
(107)

Sprache

Englisch
(107)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elektronische Zeitschriftenbibliothek (Open access)
(107)
NUS Single-Journal Subscriptions
(107)
MEDLINE
(100)

Menü

Weitere Dienste

Einstellungen

Identification of a novel estrogen response element in the Breast Cancer Resistance Protein (ABCG2) gene

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer

Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post- transcriptional increases in cyclin D proteins

Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein

Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias

Targeting RNA Polymerase I with an Oral Small Molecule CX-5461 Inhibits Ribosomal RNA Synthesis and Solid Tumor Growth

Epidermal Growth Factor Receptor and Mutant p53 Expand an Esophageal Cellular Subpopulation Capable of Epithelial-to-Mesenchymal Transition through ZEB Transcription Factors

The Kynurenine Pathway in Brain Tumor Pathogenesis

γ-Secretase Inhibitors Enhance Temozolomide Treatment of Human Gliomas by Inhibiting Neurosphere Repopulation and Xenograft Recurrence

Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)h:quinone oxidoreductase 1 Role of 17-AAG hydroquinone in heat shock protein 90 inhibition

Kinetic analysis of epidermal growth factor receptor somatic mutant proteins shows increased sensitivity to the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib

Transport of methotrexate, methotrexate polyglutamates, and 17β-estradiol 17-(β-D-glucuronide) by ABCG2: Effects of acquired mutations at R482 on methotrexate transport

Differing Src Signaling Levels Have Distinct Outcomes in Drosophila

Characterization of Gene―Environment Interactions for Colorectal Cancer Susceptibility Loci

The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux

Letrozole inhibits Tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status

β-Glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells

Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues : Implications for drug resistance, tissue-specific expression, and alternative promoter usage

LPA Receptor Heterodimerizes with CD97 to Amplify LPA-Initiated RHO-Dependent Signaling and Invasion in Prostate Cancer Cells

Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux

The protein kinase Cβ-selective inhibitor, enzastaurin (LY317615.HCI), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts

Autoantibody Signatures Involving Glycolysis and Splicesome Proteins Precede a Diagnosis of Breast Cancer among Postmenopausal Women

Hedgehog Signaling Inhibition Blocks Growth of Resistant Tumors through Effects on Tumor Microenvironment

Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas

Serum antibodies to huntingtin interacting protein. 1: A new blood test for prostate cancer

Aktive Filter

Suchergebnisse filtern